ID   PCY1A_HUMAN             Reviewed;         367 AA.
AC   P49585; A9LYK9; D3DXB1; Q86Y88;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   15-JAN-2008, sequence version 2.
DT   10-MAY-2017, entry version 158.
DE   RecName: Full=Choline-phosphate cytidylyltransferase A;
DE            EC=2.7.7.15 {ECO:0000250|UniProtKB:P19836};
DE   AltName: Full=CCT-alpha;
DE   AltName: Full=CTP:phosphocholine cytidylyltransferase A;
DE            Short=CCT A;
DE            Short=CT A;
DE   AltName: Full=Phosphorylcholine transferase A;
GN   Name=PCYT1A; Synonyms=CTPCT, PCYT1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=7918629; DOI=10.1016/0167-4781(94)90056-6;
RA   Kalmar G.B., Kay R.J., Lachance A.C., Cornell R.B.;
RT   "Primary structure and expression of a human CTP:phosphocholine
RT   cytidylyltransferase.";
RL   Biochim. Biophys. Acta 1219:328-334(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   SeattleSNPs variation discovery resource;
RL   Submitted (NOV-2007) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   MECHANISM OF CYTIDYLYLTRANSFERASE ACTIVATION.
RX   PubMed=8155650; DOI=10.1021/bi00180a029;
RA   Johnson J.E., Cornell R.B.;
RT   "Membrane-binding amphipathic alpha-helical peptide derived from
RT   CTP:phosphocholine cytidylyltransferase.";
RL   Biochemistry 33:4327-4335(1994).
RN   [6]
RP   CIRCULAR DICHROISM, AND STRUCTURE BY NMR OF 236-268 AND 267-288.
RX   PubMed=8810902; DOI=10.1021/bi960821+;
RA   Dunne S.J., Cornell R.B., Johnson J.E., Glover N.R., Tracey A.S.;
RT   "Structure of the membrane binding domain of CTP:phosphocholine
RT   cytidylyltransferase.";
RL   Biochemistry 35:11975-11984(1996).
RN   [7]
RP   IN VITRO INTERCHAIN DISULFIDE BOND, AND MUTAGENESIS OF CYS-37.
RX   PubMed=15069071; DOI=10.1074/jbc.M403311200;
RA   Xie M., Smith J.L., Ding Z., Zhang D., Cornell R.B.;
RT   "Membrane binding modulates the quaternary structure of
RT   CTP:phosphocholine cytidylyltransferase.";
RL   J. Biol. Chem. 279:28817-28825(2004).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-362, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-362, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-343; SER-347; SER-352
RP   AND SER-362, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-315; SER-319; SER-343;
RP   SER-347 AND SER-362, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-8, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-362, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-362, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [17]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-233; SER-315; SER-319;
RP   SER-331; THR-342; SER-343 AND SER-347, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-343; SER-347 AND
RP   SER-362, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [20]
RP   VARIANTS SMDCRD THR-99; VAL-99; LYS-129; ALA-150; LEU-191 AND SER-223.
RX   PubMed=24387990; DOI=10.1016/j.ajhg.2013.11.018;
RA   Hoover-Fong J., Sobreira N., Jurgens J., Modaff P., Blout C.,
RA   Moser A., Kim O.H., Cho T.J., Cho S.Y., Kim S.J., Jin D.K., Kitoh H.,
RA   Park W.Y., Ling H., Hetrick K.N., Doheny K.F., Valle D., Pauli R.M.;
RT   "Mutations in PCYT1A, encoding a key regulator of phosphatidylcholine
RT   metabolism, cause spondylometaphyseal dysplasia with cone-rod
RT   dystrophy.";
RL   Am. J. Hum. Genet. 94:105-112(2014).
RN   [21]
RP   VARIANT SMDCRD LYS-129.
RX   PubMed=24387991; DOI=10.1016/j.ajhg.2013.11.022;
RA   Yamamoto G.L., Baratela W.A., Almeida T.F., Lazar M., Afonso C.L.,
RA   Oyamada M.K., Suzuki L., Oliveira L.A., Ramos E.S., Kim C.A.,
RA   Passos-Bueno M.R., Bertola D.R.;
RT   "Mutations in PCYT1A cause spondylometaphyseal dysplasia with cone-rod
RT   dystrophy.";
RL   Am. J. Hum. Genet. 94:113-119(2014).
CC   -!- FUNCTION: Controls phosphatidylcholine synthesis.
CC   -!- CATALYTIC ACTIVITY: CTP + phosphocholine = diphosphate + CDP-
CC       choline. {ECO:0000250|UniProtKB:P19836}.
CC   -!- ENZYME REGULATION: By phosphorylation. {ECO:0000250}.
CC   -!- PATHWAY: Phospholipid metabolism; phosphatidylcholine
CC       biosynthesis; phosphatidylcholine from phosphocholine: step 1/2.
CC       {ECO:0000250|UniProtKB:P19836}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000250|UniProtKB:P19836}.
CC   -!- INTERACTION:
CC       Q9Y5K3-3:PCYT1B; NbExp=4; IntAct=EBI-2563309, EBI-12280028;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000250}. Membrane
CC       {ECO:0000250}; Peripheral membrane protein {ECO:0000250}. Note=It
CC       can interconvert between an inactive cytosolic form and an active
CC       membrane-bound form. {ECO:0000250}.
CC   -!- PTM: The serine residues of the C-terminus are phosphorylated. The
CC       inactive soluble form is stabilized by phosphorylation, the active
CC       membrane bound form is promoted by anionic lipids or
CC       diacylglycerol, and is stabilized by dephosphorylation (By
CC       similarity). {ECO:0000250}.
CC   -!- PTM: Monoubiquitinated by the SCF(FBXL2) complex, leading to
CC       proteasomal degradation. {ECO:0000250}.
CC   -!- DISEASE: Spondylometaphyseal dysplasia with cone-rod dystrophy
CC       (SMDCRD) [MIM:608940]: A disorder characterized by postnatal
CC       growth deficiency resulting in profound short stature, rhizomelia
CC       with bowing of the lower extremities, platyspondyly with anterior
CC       vertebral protrusions, progressive metaphyseal irregularity and
CC       cupping with shortened tubular bones, and early-onset progressive
CC       visual impairment associated with a pigmentary maculopathy and
CC       electroretinographic evidence of cone-rod dysfunction.
CC       {ECO:0000269|PubMed:24387990, ECO:0000269|PubMed:24387991}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the cytidylyltransferase family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/pcyt1a/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L28957; AAA72127.1; -; mRNA.
DR   EMBL; EU280320; ABX44666.1; -; Genomic_DNA.
DR   EMBL; CH471191; EAW53655.1; -; Genomic_DNA.
DR   EMBL; CH471191; EAW53662.1; -; Genomic_DNA.
DR   EMBL; BC046355; AAH46355.1; -; mRNA.
DR   CCDS; CCDS3315.1; -.
DR   PIR; S50145; S50145.
DR   RefSeq; NP_001299602.1; NM_001312673.1.
DR   RefSeq; NP_005008.2; NM_005017.3.
DR   UniGene; Hs.135997; -.
DR   UniGene; Hs.732774; -.
DR   ProteinModelPortal; P49585; -.
DR   SMR; P49585; -.
DR   BioGrid; 111157; 11.
DR   IntAct; P49585; 18.
DR   STRING; 9606.ENSP00000292823; -.
DR   DrugBank; DB00122; Choline.
DR   DrugBank; DB00709; Lamivudine.
DR   iPTMnet; P49585; -.
DR   PhosphoSitePlus; P49585; -.
DR   BioMuta; PCYT1A; -.
DR   DMDM; 166214967; -.
DR   EPD; P49585; -.
DR   MaxQB; P49585; -.
DR   PaxDb; P49585; -.
DR   PeptideAtlas; P49585; -.
DR   PRIDE; P49585; -.
DR   DNASU; 5130; -.
DR   Ensembl; ENST00000292823; ENSP00000292823; ENSG00000161217.
DR   Ensembl; ENST00000431016; ENSP00000394617; ENSG00000161217.
DR   GeneID; 5130; -.
DR   KEGG; hsa:5130; -.
DR   UCSC; uc003fwf.2; human.
DR   CTD; 5130; -.
DR   DisGeNET; 5130; -.
DR   GeneCards; PCYT1A; -.
DR   H-InvDB; HIX0024337; -.
DR   HGNC; HGNC:8754; PCYT1A.
DR   HPA; HPA035428; -.
DR   MalaCards; PCYT1A; -.
DR   MIM; 123695; gene.
DR   MIM; 608940; phenotype.
DR   neXtProt; NX_P49585; -.
DR   OpenTargets; ENSG00000161217; -.
DR   Orphanet; 85167; Spondylometaphyseal dysplasia - cone-rod dystrophy.
DR   PharmGKB; PA33099; -.
DR   eggNOG; KOG2804; Eukaryota.
DR   eggNOG; COG0615; LUCA.
DR   GeneTree; ENSGT00390000000269; -.
DR   HOGENOM; HOG000230945; -.
DR   HOVERGEN; HBG053531; -.
DR   InParanoid; P49585; -.
DR   KO; K00968; -.
DR   PhylomeDB; P49585; -.
DR   TreeFam; TF106336; -.
DR   BioCyc; MetaCyc:HS08577-MONOMER; -.
DR   Reactome; R-HSA-1483191; Synthesis of PC.
DR   SIGNOR; P49585; -.
DR   UniPathway; UPA00753; UER00739.
DR   GeneWiki; PCYT1A; -.
DR   GenomeRNAi; 5130; -.
DR   PMAP-CutDB; P49585; -.
DR   PRO; PR:P49585; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000161217; -.
DR   CleanEx; HS_PCYT1A; -.
DR   ExpressionAtlas; P49585; baseline and differential.
DR   Genevisible; P49585; HS.
DR   GO; GO:0005829; C:cytosol; IEA:UniProtKB-SubCell.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; ISS:UniProtKB.
DR   GO; GO:0042587; C:glycogen granule; ISS:UniProtKB.
DR   GO; GO:0005635; C:nuclear envelope; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IEA:Ensembl.
DR   GO; GO:0005516; F:calmodulin binding; IEA:Ensembl.
DR   GO; GO:0004105; F:choline-phosphate cytidylyltransferase activity; ISS:UniProtKB.
DR   GO; GO:0031210; F:phosphatidylcholine binding; IEA:Ensembl.
DR   GO; GO:0042803; F:protein homodimerization activity; IEA:Ensembl.
DR   GO; GO:0006657; P:CDP-choline pathway; ISS:UniProtKB.
DR   GO; GO:0006656; P:phosphatidylcholine biosynthetic process; ISS:UniProtKB.
DR   Gene3D; 3.40.50.620; -; 1.
DR   InterPro; IPR004821; Cyt_trans-like.
DR   InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR   Pfam; PF01467; CTP_transf_like; 1.
DR   TIGRFAMs; TIGR00125; cyt_tran_rel; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Complete proteome; Cone-rod dystrophy; Cytoplasm;
KW   Disease mutation; Dwarfism; Lipid biosynthesis; Lipid metabolism;
KW   Membrane; Nucleotidyltransferase; Phospholipid biosynthesis;
KW   Phospholipid metabolism; Phosphoprotein; Reference proteome; Repeat;
KW   Transferase; Ubl conjugation.
FT   CHAIN         1    367       Choline-phosphate cytidylyltransferase A.
FT                                /FTId=PRO_0000208453.
FT   REPEAT      319    324       1.
FT   REPEAT      329    333       2; approximate.
FT   REPEAT      343    348       3.
FT   NP_BIND      84     92       CTP. {ECO:0000250|UniProtKB:P19836}.
FT   NP_BIND     168    169       CTP. {ECO:0000250|UniProtKB:P19836}.
FT   NP_BIND     196    200       CTP. {ECO:0000250|UniProtKB:P19836}.
FT   REGION      228    287       Amphipathic. {ECO:0000255}.
FT   REGION      256    288       3 X 11 AA approximate tandem repeats.
FT   REGION      319    348       3 X repeats.
FT   BINDING     122    122       CTP. {ECO:0000250|UniProtKB:P19836}.
FT   BINDING     122    122       Substrate.
FT                                {ECO:0000250|UniProtKB:P19836}.
FT   BINDING     151    151       Substrate.
FT                                {ECO:0000250|UniProtKB:P19836}.
FT   BINDING     173    173       CTP. {ECO:0000250|UniProtKB:P19836}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:22814378}.
FT   MOD_RES       8      8       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     233    233       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     315    315       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     319    319       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     321    321       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P19836}.
FT   MOD_RES     322    322       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P19836}.
FT   MOD_RES     323    323       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P49586}.
FT   MOD_RES     325    325       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P49586}.
FT   MOD_RES     329    329       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P19836}.
FT   MOD_RES     331    331       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     333    333       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P19836}.
FT   MOD_RES     342    342       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     343    343       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     347    347       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     352    352       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     362    362       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:24275569}.
FT   VARIANT      99     99       A -> T (in SMDCRD; dbSNP:rs587777191).
FT                                {ECO:0000269|PubMed:24387990}.
FT                                /FTId=VAR_071083.
FT   VARIANT      99     99       A -> V (in SMDCRD; dbSNP:rs587777189).
FT                                {ECO:0000269|PubMed:24387990}.
FT                                /FTId=VAR_071084.
FT   VARIANT     129    129       E -> K (in SMDCRD; dbSNP:rs587777194).
FT                                {ECO:0000269|PubMed:24387990,
FT                                ECO:0000269|PubMed:24387991}.
FT                                /FTId=VAR_071085.
FT   VARIANT     150    150       P -> A (in SMDCRD; dbSNP:rs587777190).
FT                                {ECO:0000269|PubMed:24387990}.
FT                                /FTId=VAR_071086.
FT   VARIANT     191    191       F -> L (in SMDCRD; dbSNP:rs587777195).
FT                                {ECO:0000269|PubMed:24387990}.
FT                                /FTId=VAR_071087.
FT   VARIANT     223    223       R -> S (in SMDCRD; dbSNP:rs540053239).
FT                                {ECO:0000269|PubMed:24387990}.
FT                                /FTId=VAR_071088.
FT   MUTAGEN      37     37       C->S: Abolishes formation of the
FT                                interchain disulfide that can be observed
FT                                when the enzyme is treated with copper
FT                                phenanthrolene (in vitro).
FT                                {ECO:0000269|PubMed:15069071}.
FT   CONFLICT    251    251       K -> E (in Ref. 1; AAA72127).
FT                                {ECO:0000305}.
SQ   SEQUENCE   367 AA;  41731 MW;  38CE9D5CF2E2AEE2 CRC64;
     MDAQCSAKVN ARKRRKEAPG PNGATEEDGV PSKVQRCAVG LRQPAPFSDE IEVDFSKPYV
     RVTMEEASRG TPCERPVRVY ADGIFDLFHS GHARALMQAK NLFPNTYLIV GVCSDELTHN
     FKGFTVMNEN ERYDAVQHCR YVDEVVRNAP WTLTPEFLAE HRIDFVAHDD IPYSSAGSDD
     VYKHIKEAGM FAPTQRTEGI STSDIITRIV RDYDVYARRN LQRGYTAKEL NVSFINEKKY
     HLQERVDKVK KKVKDVEEKS KEFVQKVEEK SIDLIQKWEE KSREFIGSFL EMFGPEGALK
     HMLKEGKGRM LQAISPKQSP SSSPTRERSP SPSFRWPFSG KTSPPCSPAN LSRHKAAAYD
     ISEDEED
//
